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Obesity: knowledge, care, and 
commitment, but not yet cure
Obesidade: ainda sem a cura, mas necessitando  
de conhecimento, cuidados e comprometimento
Bruno Geloneze1, Marcio C. Mancini2, Walmir Coutinho3
“The devil has put a penalty on all things we enjoy in life. 
Either we suffer in health or we suffer in soul or we get fat.” 
Albert Einstein 
“I’m fat, but I’m thin inside... there’s a thin man inside every fat man.”
George Orwell
The management of obesity is a major public health and economic global concern. Few diseases or conditions are as common or have the health implications of obe-
sity. Although obesity can be simply defined as a disorder of excess body fat, the major 
pathobiology occurs in other tissues such as hepatic, vascular system, musculoskeletal, 
etc (1). Obesity is undoubtedly an important risk factor for serious diseases such as 
cardiovascular diseases, type 2 diabetes and certain types of cancer (2). 
Additionally, the percentage of the world population affected by obesity is increas-
ing at an alarming rate. Worldwide, an estimated 1.6 billion adults (aged 15 years and 
older) were overweight (BMI: 25-30 kg/m2), and 400 million were obese (BMI > 30) 
in 2005. By 2015, it is expected there will be 2.3 billion overweight and more than 
700 million obese adults worldwide (3).
Given the financial burden and the essential clinical infrastructure needed to treat 
this high-risk population, major resources will be required to provide adequate care 
(4). Furthermore, the globalization of obesity-related diabetes requires that healthcare 
providers are kept up-to-date with the latest advances in obesity management strate-
gies. This supplement contains a series of state-of-the-art reviews and some original 
research articles in the field of obesity and related conditions. The overall knowledge 
of this content provides a concise, to-the-point, theoretical and pragmatic approach, 
which will make possible to provide optimal care for obese patients, reinforcing our 
commitment and hope of finding a, not yet available, cure for obesity. 
Environmental factors, such as social networks and global “westernization” with 
respect to dietary preferences and sedentary lifestyle have a strong influence on obesity 
pandemics. There is a new player on this scenario. The gut microbial flora (microbiota) 
plays a role in converting nutrients into calories. Glycans, such as plant polysaccharides, 
cannot be digested with human enzymes, so bacterial enzymes are needed. The gut 
microbiota differs in obese and non-obese people. Weight gain in the human popula-
tion grossly follows the level of antibiotic usage possibly modifying our gut microbiota. 
Probiotics can be defined as living organisms (Lactobacillus, for example) which ben-
eficially affect the host by improving its intestinal microbial balance. Probiotics are 
increasingly used in human food. Yogurts and other fermented foods now commonly 
contain Lactobacillus and Bifidobacterium. Probiotics are used as adjuvant in many 
treatments for conditions ranging from diarrhea to the prevention of intestinal diseases 
(5). Their role in long-term weight gain must be evaluated.
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Over consumption of saturated fats and trans fatty 
acids or carbohydrates with poor nutritional value 
may also constitute another important factor contrib-
uting to body fat accumulation. Nevertheless, even 
though it is important to educate people towards 
healthier food habits and a more active lifestyle, per-
sonal responsibility is neither the only nor perhaps 
even the primary determining factor for success. In-
deed, considering that people live in complex social 
frameworks, that can potentially limit their personal 
choices, long term health concerns are not usually 
the main determinant of eating behavior.
The physiological processes which drive all of us to 
seek and ingest food and limit energy expenditure during 
periods of negative balance provide an irresistible drive 
to regain lost adipose stores in weight-reduced obese 
individuals. This provides a potential basis for the well-
recognized difficulty of maintaining weight loss. For 
this reason, prevention of obesity and identification of 
factors that promote the development of central neural 
pathways which enhance the sensitivity to negative feed-
back signals from the periphery should be a major focus 
of research. The overall goal should be targeted to a bet-
ter understanding of the central mechanisms underlying 
body fat accumulation and weight regain, which might 
lead to the development of new therapeutic strategies, 
based on preventing the whole process, rather than deal-
ing with its consequences in already obese individuals.
Bariatric surgery is an alternative and extreme ap-
proach for treating severely obese patients. Data are 
commendable and underscore the redefinition of the 
field of bariatric surgery. The resolution of the meta-
bolic syndrome and, in some cases, the resolution or 
control of type 2 diabetes within such a short period 
is nothing short of remarkable when comparing this 
with all available medical alternatives. The impressive 
results of these studies, remind us that this is, indeed, 
a metabolic surgery, and not just a weight loss surgery 
(6). On the other hand, it is time for some caution. 
Metabolic surgery classical techniques: open or lap-
aroscopic gastric bypass and biliopancreatic diversion 
have impressive results and they must not be replaced 
by new techniques, unless they prove to be superior 
in efficacy and safety terms. Hence, bariatric surgery 
could be defined as a programmed undernutrition and 
safety should always be viewed as a major concern.
This discussion reinforces the need of consider-
ing all the efforts to assist our patients, but always 
based on robust scientific evidence. The practice 
of evidence-based medicine requires the conscien-
tious and judicious application of the best available 
evidence from clinical research to support the whole 
clinical decision making process. It requires expertise 
in order to understand the context of the patient and 
to incorporate the patient’s values and preferences 
into evidence-based decisions (7). 
Endocrinologists are considered cognitive special-
ists, physicians who use their intellect to diagnose, 
prognosticate, and treat patients with endocrine or 
metabolic disorders. For the most part, the use of ge-
nomics, molecular biology, physiology, pathophysiol-
ogy, and pharmacology distinguishes these clinicians 
from their colleagues. With the advance of evidence-
based medicine, endocrinologists are faced with two 
new challenges: first, to incorporate this approach to 
their practices, and second, to sensitize other special-
ists to embrace pathophysiology-based decision mak-
ing into their practices.
Although experts agree that obesity management 
requires long-term behavioral, medical, or surgical 
intervention, there are still a large number of ap-
proved and non-approved commercial weight-loss 
treatments and programs used to influence vulner-
able and susceptible consumers, mostly exploring 
unrealistic expectations and false beliefs. It is time we 
put an end to this nonsense practice. Health profes-
sionals must be taught evidence-based principles of 
obesity management to ensure they can understand 
and provide weight management treatments with 
proven safety and efficacy.
Finally, we need to expand our efforts towards 
primary prevention, by advocating healthier lifestyle 
and eating habits. Every resource available should be 
incorporated, much beyond scientific manuscripts, 
such as lay media campaigns, school and workplace 
based partnerships and legislation initiatives.
We hope this Obesity Research supplement in 
Brazilian Archives of Endocrinology and Metabolism 
can provide clinicians, clinical and basic researchers 
with useful insights into the complex obesity prob-
lem, and remind us of our role in the fight against 
this challenging epidemic. 
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